Ilodecakin

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameIlodecakin
Drug Alias NameHuman recombinant interleukin 10 (Merck)Interleukin-10 (Merck)rhIL-10 (Merck)rIL-10 (Merck)SCH-52000
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-10 replacements
TargetsInterleukin 10 receptor
Therapy Area/IndicationsRejection of organ transplantationWounds and InjuriesGrowth Disorders +[28] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArmo BiosciencesRenovoMerck Sharp & Dohme Corp +[5] 
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationWounds and InjuriesGrowth Disorders +[28] 

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG